CN113980853B - Lactic acid-producing lactococcus garvieae WBT0008 and application thereof - Google Patents

Lactic acid-producing lactococcus garvieae WBT0008 and application thereof Download PDF

Info

Publication number
CN113980853B
CN113980853B CN202111336937.2A CN202111336937A CN113980853B CN 113980853 B CN113980853 B CN 113980853B CN 202111336937 A CN202111336937 A CN 202111336937A CN 113980853 B CN113980853 B CN 113980853B
Authority
CN
China
Prior art keywords
lactic acid
wbt0008
lactococcus garvieae
culture medium
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202111336937.2A
Other languages
Chinese (zh)
Other versions
CN113980853A (en
Inventor
王佰涛
刘德海
杨文玲
雷高
权淑静
李珊珊
刁文涛
王继雯
陈国参
李寒冰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Academy Of Sciences Institute Of Biology LLC
Original Assignee
Henan Academy Of Sciences Institute Of Biology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Academy Of Sciences Institute Of Biology LLC filed Critical Henan Academy Of Sciences Institute Of Biology LLC
Priority to CN202111336937.2A priority Critical patent/CN113980853B/en
Publication of CN113980853A publication Critical patent/CN113980853A/en
Application granted granted Critical
Publication of CN113980853B publication Critical patent/CN113980853B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23BPRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B4/00General methods for preserving meat, sausages, fish or fish products
    • A23B4/14Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20Organic compounds; Microorganisms; Enzymes
    • A23B4/22Microorganisms; Enzymes; Antibiotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/56Lactic acid
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to lactic acid-producing lactococcus garvieae WBT0008 and application thereof, which can effectively solve the problems of high yield of lactic acid and preparation of preservative and inhibition of harmful bacteria, and one lactic acid-producing lactococcus garvieae WBT0008 is classified and named as lactococcus garvieae @Lactococcus garvieae) The application of the lactococcus garvieae WBT0008 in lactic acid production, the application in preparing the bacteria inhibiting agent and the fresh beefsteak preservative is preserved in China general microbiological culture Collection center with the preservation number of CGMCC No.22576 and the preservation date of 2021, 5 and 20. The lactococcus garvieae WBT0008 is effectively used for preparing high-yield lactic acid, inhibiting harmful bacteria and fresh-keeping fresh steak, and has the advantages of simple preparation and application methods and environmental protection.

Description

Lactic acid-producing lactococcus garvieae WBT0008 and application thereof
Technical Field
The invention relates to a microorganism, in particular to lactic acid-producing lactococcus garvieae WBT0008 and application thereof.
Background
Lactic acid bacteria are widely used as probiotics which are in close contact with human life in various fields such as food, feed, medicine and the like, and are recognized as food-grade safe strains. In the food industry, the application history of the lactobacillus is long, and the lactobacillus has application in various foods such as meat, eggs, milk and the like, so that the flavor of the foods can be improved, and the nutritional value of the foods can be improved. In the feed industry, lactic acid bacteria can improve the feed utilization rate, improve the cultivation efficiency and reduce the use of chemical drugs and antibiotics. In the medical field, lactobacillus can regulate the balance of intestinal flora of the organism, prevent and treat cardiovascular diseases, and improve the oxidation resistance and immunity of the organism. Lactic acid bacteria not only have various probiotic functions, but also can produce various active metabolites, wherein lactic acid as a main metabolite produced by fermentation of lactic acid bacteria can exhibit the ability to inhibit growth of various harmful bacteria. The research finds that pathogenic bacteria in food are often important factors causing food spoilage and affecting food safety, and the chemical and physical preservation means used at present have great influence on the taste of preserved food, so that the biological preservation means becomes a novel technology in food preservation application. Lactococcus garvieae is an important probiotic, has more application in food fermentation in recent years, but has less application in high yield of lactic acid, inhibition of growth of harmful bacteria and prolongation of food fresh-keeping time, so that the lactic acid and fermentation products thereof are produced by using the lactococcus garvieae to inhibit growth of harmful bacteria in food, and the prolongation of food fresh-keeping time can overcome the prior technical defects, show obvious advantages and have wide application prospect, but has no public report so far.
Disclosure of Invention
Aiming at the situation, the invention aims to overcome the defects of the prior art and provide the lactic acid-producing lactococcus garvieae WBT0008 and the application thereof, which can effectively solve the problems of high lactic acid production, preparation of preservative and inhibition of harmful bacteria.
The technical scheme is that the lactic acid-producing lactococcus garvieae WBT0008 is classified and named as lactococcus garvieae (Lactococcus garvieae), and is preserved in China general microbiological culture Collection center (CGMCC) No.22576, and the preservation date is 2021, 5 months and 20, and the preservation address is: the institute of microorganisms of national academy of sciences of China, national institute of sciences, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing;
the application of the lactococcus garvieae WBT0008 in lactic acid production;
the application of the lactococcus garvieae WBT0008 in preparing the preparation of the bacteria agent for inhibiting the harmful bacteria, wherein the harmful bacteria are staphylococcus aureus, salmonella or coliform;
the application of the lactococcus garvieae WBT0008 in preparing fresh steak preservative.
The invention is a novel screened strain of lactococcus garvieae WBT0008, can be effectively used for preparing high-yield lactic acid, inhibiting harmful bacteria and fresh-keeping fresh steak, has simple preparation and application methods, is green and environment-friendly, provides a novel strain of lactococcus garvieae, exploits a novel application of the lactococcus garvieae, and has wide application prospect and huge economic and social benefits.
Drawings
FIG. 1 is a graph showing the variation of the 24-hour lactic acid content of the lactococcus garvieae of the present invention.
Detailed Description
The following describes in detail the embodiments of the present invention with reference to specific cases and examples.
Example 1
In the specific implementation of the invention, a lactic acid producing strain WBT0008, classified and named as lactococcus garvieae (Lactococcus garvieae), is prepared by taking soil samples around Henan Jiyuan pig farm, weighing 1g of the soil samples, preparing 10mL of suspension by using sterile water, and then sequentially diluting into 10 -3 、10 -4 、10 -5 Sample diluent is respectively absorbed with 0.1mL and coated on a calcium carbonate screening plate, the sample diluent is cultured for 48 hours in a constant temperature incubator at 37 ℃, a transparent circle is observed, a strain with obvious transparent circle is selected, a strain with the number of WBT0008 is obtained through screening, and the calcium carbonate screening plate: 10g of peptone, 10g of beef extract, 5g of yeast extract, 2g of diammonium citrate, 5g of sodium acetate, 20g of glucose, 80mL of Tween, 0.5g of magnesium sulfate,0.25g of manganese sulfate, 10g of calcium carbonate and 18g of agar, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, cooling for standby, and preparing a flat plate; screening to obtain strain with WBT0008, classified and named as lactococcus garvieae (Lactococcus garvieae), and preserving in China general microbiological culture Collection center (CGMCC) with preservation number of 22576, and preserving date of 2021, 5 months and 20, and preserving address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
Example 2
The application of the strain WBT0008 in lactic acid production comprises the following steps:
(1) Activating strains and culturing seeds: inoculating the frozen preserved strain WBT0008 into a seed culture medium according to the inoculum size of 1% after activation, and culturing at 37 ℃ for 24 hours at 180 r/min; the seed culture medium is as follows: 50g of glucose, 10g of peptone, 10g of yeast extract, 5g of sodium acetate, 0.2g of diammonium citrate, 0.2g of dipotassium hydrogen phosphate, 80mL of Tween, 0.2g of magnesium sulfate, 0.02g of manganese sulfate, 0.01g of ferrous sulfate and pH6.3-6.6, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, and cooling for later use;
(2) Lactic acid preparation: inoculating the seed solution into MRS culture medium according to volume of 2% of MRS culture medium, shake culturing at 37deg.C and 180r/min for 48 hr to obtain fermentation broth, namely lactic acid;
the MRS liquid culture medium comprises the following components: 10g of peptone, 10g of beef extract, 5g of yeast extract, 2g of diammonium citrate, 5g of sodium acetate, 20g of glucose, 80mL of Tween, 0.5g of magnesium sulfate and 0.25g of manganese sulfate, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, and cooling to obtain the beef extract;
(3) And (3) measuring the content of lactic acid:
sampling the prepared fermentation liquor lactic acid at 4h, 8h, 12h, 16h, 20h and 24h, repeating each group of the fermentation liquor lactic acid at three times, centrifuging at the temperature of 4 ℃ and under the condition of 12000r/min for 8min, taking the supernatant to measure the content of lactic acid, oxidizing the lactic acid under the action of lactic acid dehydrogenase to generate pyruvic acid, reducing MTT to generate a purple substance, wherein the substance has a characteristic absorption peak at 570nm, calculating the content of lactic acid to be 2-11 g/L/mL by utilizing the proportional relation between the lactic acid and the concentration of lactic acid, and determining the content of lactic acid by the following formula:
Figure GDA0004190164070000031
wherein: a represents absorbance of fermentation supernatant, A 0 The absorbance of the blank is represented by K, the slope of the standard curve, the intercept of the standard curve, and the conversion coefficient by 1176.67.
As shown in FIG. 1, the maximum lactic acid production of the strain WBT0008 within 24 hours reached 10.60g/L, indicating that the strain was able to achieve high yields of lactic acid in a short period of time, which is an excellent strain for efficient fermentative production of lactic acid.
Example 3
The application method of the lactococcus garvieae WBT0008 in preparing the bacteria agent for inhibiting harmful bacteria comprises the following steps:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for shaking culture at 37 ℃ for 48 hours, and the concentration of the cultured thalli is 1 multiplied by 10 8 Centrifuging the CFU/mL and then the bacterial liquid at the temperature of 4 ℃ and 12000r/min for 20min to obtain a supernatant, thereby obtaining a bacteriostatic agent for inhibiting harmful bacteria;
the harmful bacteria are staphylococcus aureus, salmonella or coliform bacteria.
(2) Antibacterial Activity test
The antibacterial activity test adopts a filter paper sheet method, harmful bacteria are inoculated in LB liquid culture medium, shaking culture is carried out for 24 hours at 37 ℃, 200 mu L of bacteria liquid is absorbed and evenly coated on a nutrient agar plate, then a sterilized filter paper sheet with the diameter of 5mm is placed on the coated plate, 10 mu L of a centrifugal supernatant of a lactococcus garvieae agent is dripped on the filter paper sheet, and the culture is carried out for 24 hours at 37 ℃, and the diameter of an antibacterial ring is observed and measured.
Example 4
The application of the lactococcus garvieae WBT0008 in inhibiting harmful bacteria comprises the following steps:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for shaking culture at 37 ℃ for 48 hours, and the concentration of the cultured thalli is 1 multiplied by 10 8 CFU/mL, then the bacterial liquid is processed at 4 DEG CCentrifuging at 12000r/min for 20min, and collecting supernatant for antibacterial test.
(2) Antibacterial Activity test
The antibacterial activity test adopts a filter paper sheet method, salmonella ATCC14028 is inoculated in LB liquid medium for shaking culture at 37 ℃ for 24 hours, 200 mu L of bacteria liquid is absorbed and uniformly coated on a nutrient agar plate, then two sterilized filter paper sheets with the diameter of 5mm are placed on the coated plate, 10 mu L of strain WBT0008 centrifugal supernatant is dripped on the filter paper sheet by an experimental group, 10 mu L of sterile water is dripped by a control group for culturing at 37 ℃ for 24 hours, the diameter of a bacteria inhibition zone is observed and measured, and the outer diameter of the salmonella inhibition zone of the experimental group is found to reach 12.6 mm, so that the growth of salmonella can be truly inhibited by the strain WBT0008 supernatant, and the effect is obvious.
Example 5
The application of the strain lactococcus garvieae WBT0008 in inhibiting harmful bacteria comprises the following steps:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for shaking culture at 37 ℃ for 48 hours, and the concentration of the cultured thalli is 1 multiplied by 10 8 CFU/mL, and then the bacterial liquid is centrifuged for 20min at the temperature of 4 ℃ and 12000r/min to obtain supernatant for bacteriostasis test.
(2) Antibacterial Activity test
The antibacterial activity test adopts a filter paper sheet method, staphylococcus aureus ATCC25923 is inoculated in LB liquid culture medium for shaking culture at 37 ℃ for 24 hours, 200 mu L of bacteria liquid is absorbed and uniformly coated on a nutrient agar plate, then two sterilized filter paper sheets with the diameter of 5mm are placed on the coated plate, 10 mu L of strain WBT0008 centrifugal supernatant is dripped on the filter paper sheet by an experimental group, 10 mu L of sterile water is dripped by a control group, the culture is carried out for 24 hours at 37 ℃, the diameter of a bacteria inhibition zone is observed and measured, and the outer diameter of the bacteria inhibition zone of the staphylococcus aureus of the experimental group reaches 10.7 mm, so that the growth of staphylococcus aureus can be truly inhibited by the supernatant of the strain WBT0008, and the effect is obvious.
Example 6
The application of the strain lactococcus garvieae WBT0008 in inhibiting harmful bacteria comprises the following steps:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for shaking culture at 37 ℃ for 48 hours, and the concentration of the cultured thalli is 1 multiplied by 10 8 CFU/mL, and then the bacterial liquid is centrifuged for 20min at the temperature of 4 ℃ and 12000r/min to obtain supernatant for bacteriostasis test.
(2) Antibacterial Activity test
The antibacterial activity test adopts a filter paper sheet method, escherichia coli ATCC25922 is inoculated in an LB liquid culture medium for shake cultivation for 24 hours at 37 ℃, 200 mu L of bacteria liquid is absorbed and uniformly coated on a nutrient agar plate, then two sterilized filter paper sheets with the diameter of 5mm are placed on the coated plate, 10 mu L of strain WBT0008 centrifugal supernatant is dripped on the filter paper sheet by an experimental group, 10 mu L of sterile water is dripped on a control group for cultivation for 24 hours at 37 ℃, the diameter of a bacteria inhibition zone is observed and measured, and the outer diameter of the bacteria inhibition zone of the experimental group gold escherichia coli reaches 11.2 mm, so that the growth of escherichia coli can be truly inhibited by the supernatant of the strain WBT0008, and the effect is obvious.
Example 7
The application of the strain WBT0008 in fresh steak preservation comprises the following steps:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for 48 hours at 37 ℃ according to an inoculum size of 2 percent, and the concentration of the cultured bacteria is 3 multiplied by 10 8 CFU/mL, and then the bacterial liquid is centrifuged for 20min at the temperature of 4 ℃ and 12000r/min to obtain supernatant for bacteriostasis test.
(2) Steak fresh-keeping test
Taking steak with consistent freshness, uniformly spraying fermentation supernatant on the surface of fresh steak by using a clean sterile watering can, uniformly spraying sterile water on the surface of steak by using comparison, and then completely covering by using a sterile preservative film. Staphylococcus aureus, salmonella and coliform counts are carried out at 6h, 12h, 18h, 24h and 30h according to national standards GB4789.10-2016 staphylococcus aureus test, GB 4789.4-2016 salmonella test and GB 4789.3-2010 coliform count. The results are shown in tables 1, 2 and 3, compared with the control group, the quantity of staphylococcus aureus, salmonella and escherichia coli of the experiment group sprayed with the supernatant is obviously lower than that of the control group, the fresh-keeping effect within 30 hours is improved by 2-6 times, and the strain WBT0008 has better effect in the beef steak fresh-keeping process and higher application value.
TABLE 1 beef steak fresh test for Staphylococcus aureus number variation (lg cfu/mL)
Figure GDA0004190164070000051
Note that: the control group and the experimental group in the table are the average value of three repetitions ± standard deviation
Table 2 fresh keeping test of steak Salmonella quantity Change (lg cfu/mL)
Figure GDA0004190164070000052
Note that: the control group and the experimental group in the table are the average value of three repetitions ± standard deviation
TABLE 3 fresh-keeping test of E.coli quantity variation (lg cfu/mL)
Figure GDA0004190164070000053
Note that: the control group and the experimental group in the table are the average value of three repetitions ± standard deviation
The strain of the invention is a newly screened strain WBT0008 for producing lactic acid, which is classified and named as lactococcus garvieae (Lactococcus garvieae), and has very good beneficial technical effects through field application, and the related data are as follows:
1. screening of Strain WBT0008
Taking a soil sample around a pig farm in Henan Jiyuan City, weighing 1g of the soil sample, preparing 10mL of suspension by using sterile water, and sequentially diluting to 10 -3 、10 -4 、10 -5 Sample dilution, respectively sucking 0.1mL, coating on a calcium carbonate screening plate, culturing in a constant temperature incubator at 37deg.C for 48 hr, observing transparent rings, selecting strain with obvious transparent rings, and screeningThe strain designated WBT0008 was selected and the calcium carbonate screen plates: 10g of peptone, 10g of beef extract, 5g of yeast extract, 2g of diammonium citrate, 5g of sodium acetate, 20g of glucose, 80mL of Tween, 0.5g of magnesium sulfate, 0.25g of manganese sulfate, 10g of calcium carbonate and 18g of agar, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, cooling for later use, and preparing a flat plate.
2. Identification of strains
(1) Morphological observation
Bacterial colony of strain WBT0008 is smaller, white, smooth and glossy in surface, nearly round, orderly in edge, arranged in a chain, free of secretion and positive in gram staining.
(2) Physiological and biochemical analysis
Through physiological and biochemical experiments, the strain is found to be capable of decomposing esculin, cellobiose, maltose, mannitol, salicin, sucrose, inulin, lactose and sodium hippurate, and not capable of decomposing sorbitol and raffinose, and specific results are shown in Table 4.
TABLE 4 results of the biochemical reactions of lactococcus garvieae WBT0008
Figure GDA0004190164070000061
Note that: + indicates positive, -indicates negative
(3) Molecular biological analysis
The genome of WBT0008 strain was extracted by 16S rDNA sequence analysis using bacterial genome extraction kit. PCR was then performed, primer sequences: 27F 5'-AGAGTTTGATCCTGGCTCAG-3' 14992R 5'-GGTTACCTTGTTACGACTT-3'. Reaction system 50 μl: ddH2O 21. Mu.L, 1499r1.5. Mu.L, 27F 1.5. Mu.L, taqmix enzyme 25. Mu.L, and template DNA of the fungus sample 1. Mu.L. PCR procedure: pre-denaturation at 94℃for 4min, denaturation at 96℃for 30s, annealing at 55℃for 30s, extension at 72℃for 60s,32 cycles, extension at 72℃for 10min. And then sending the PCR product to a large gene company for sequencing, wherein the sequence information is shown in a sequence table. BLAST comparison is carried out on the 16S rDNA sequence in a database of NCBI functional network, a phylogenetic tree is constructed, and homology comparison analysis is carried out, so that the strain is found to have similar homology with the lactococcus garvieae. Combining morphological results, physiological and biochemical results and 16S rDNA sequence analysis results, determining that the strain is lactococcus garvieae, and classifying and naming the strain as lactococcus garvieae (Lactococcus garvieae), and preserving the strain in China general microbiological culture Collection center (CGMCC) with a preservation number of 22576, a preservation date of 2021, 5 months and 20 numbers and a preservation address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
16S rDNA sequence:
Figure GDA0004190164070000071
the screened lactococcus garvieae WBT0008 has good high-yield lactic acid after being applied in the field, and specific test conditions are shown in example 2, the highest yield of lactic acid in 24 hours reaches 10.60g/L, which indicates that the strain can realize high yield of lactic acid in a short time; the application of the antibacterial agent for inhibiting harmful bacteria in preparation of the antibacterial agent for inhibiting salmonella has the outer diameter of inhibition zone of 12.6 mm, proves that the supernatant of the bacterial strain WBT0008 can actually inhibit the growth of salmonella, has the outer diameter of inhibition zone of staphylococcus aureus of 10.7 mm, and has obvious effect, and the supernatant of the bacterial strain WBT0008 can actually inhibit the growth of staphylococcus aureus and the outer diameter of inhibition zone of escherichia coli of 11.2 mm, so that the supernatant of the bacterial strain WBT0008 can actually inhibit the growth of escherichia coli; the antibacterial fresh-keeping agent has remarkable antibacterial fresh-keeping effect when applied to fresh steak fresh keeping, the unit lg cfu/mL is within 30 hours, the number of staphylococcus aureus is 2.66+/-0.01, the number of salmonella is 1.28+/-0.01, and the number of escherichia coli is 1.39+/-0.03, and the fresh-keeping effect is improved by 2-6 times within 30 hours as shown in tables 1-3.
From the above, it is clear that the invention is a new screened strain of lactococcus garvieae WBT0008, can be effectively used for preparing high-yield lactic acid, inhibiting harmful bacteria and fresh-keeping fresh steak, has simple preparation and application methods, can effectively improve the food fresh-keeping effect, is environment-friendly, provides a new strain of lactococcus garvieae, exploits the new application of the lactococcus garvieae, and has wide application prospect and huge economic and social benefits.
Sequence listing
<110> biological research all of the Limited liability company of the academy of sciences of Henan province
<120> lactic acid-producing lactococcus garvieae WBT0008 and use thereof
<130> 2021
<160> 1
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1437
<212> DNA
<213> lactococcus garvieae (Lactococcus garvieae)
<400> 1
gagtttggat cctggctcag gacgaacgct ggcggcgtgc ctaatacatg caagtcgagc 60
gatgattaaa gatagcttgc tatttttatg aagagcggcg aacgggtgag taacgcgtgg 120
gaaatctgcc gagtagcggg ggacaacgtt tggaaacgaa cgctaatacc gcataacaat 180
gagaatcgca tgattcttat ttgaaagaag caattgcttc actacttgat gatcccgcgt 240
tgtattagct agttggtagt gtaaaggact accaaggcga tgatacatag ccgacctgag 300
agggtgatcg gccacactgg gactgagaca cggcccagac tcctacggga ggcagcagta 360
gggaatcttc ggcaatgggg gcaaccctga ccgagcaacg ccgcgtgagt gaagaaggtt 420
ttcggatcgt aaaactctgt tgttagagaa gaacgttaag tagagtggaa aattacttaa 480
gtgacggtat ctaaccagaa agggacggct aactacgtgc cagcagccgc ggtaatacgt 540
aggtcccaag cgttgtccgg atttattggg cgtaaagcga gcgcaggtgg tttcttaagt 600
ctgatgtaaa aggcagtggc tcaaccattg tgtgcattgg aaactgggag acttgagtgc 660
aggagaggag agtggaattc catgtgtagc ggtgaaatgc gtagatatat ggaggaacac 720
cggaggcgaa agcggctctc tggcctgtaa ctgacactga ggctcgaaag cgtggggagc 780
aaacaggatt agataccctg gtagtccacg ccgtaaacga tgagtgctag ctgtagggag 840
ctataagttc tctgtagcgc agctaacgca ttaagcactc cgcctgggga gtacgaccgc 900
aaggttgaaa ctcaaaggaa ttgacggggg cccgcacaag cggtggagca tgtggtttaa 960
ttcgaagcaa cgcgaagaac cttaccaggt cttgacatac tcgtgctatc cttagagata 1020
aggagttcct tcgggacacg ggatacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg 1080
agatgttggg ttaagtcccg caacgagcgc aacccttatt actagttgcc atcattaagt 1140
tgggcactct agtgagactg ccggtgataa accggaggaa ggtggggatg acgtcaaatc 1200
atcatgcccc ttatgacctg ggctacacac gtgctacaat ggatggtaca acgagtcgcc 1260
aacccgcgag ggtgcgctaa tctcttaaaa ccattctcag ttcggattgc aggctgcaac 1320
tcgcctgcat gaagtcggaa tcgctagtaa tcgcggatca gcacgccgcg gtgaatacgt 1380
tcccgggcct tgtacacacc gcccgtcaca ccacggaagt tgggagtacc caaagta 1437

Claims (4)

1. A strain of lactococcus garvieae WBT0008, classified and named as lactococcus garvieae @Lactococcus garvieae) The culture medium is preserved in China general microbiological culture Collection center (CGMCC) No.22576, and the preservation date is 2021, 5 and 20, and the preservation address is: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
2. A method of lactic acid production by a strain of lactococcus garvieae WBT0008 as defined in claim 1 comprising the steps of:
(1) Activating strains and culturing seeds: inoculating the frozen preserved strain WBT0008 into a seed culture medium according to the volume of 1% of the culture medium after activation, and culturing at 37 ℃ for 24 hours at 180r/min to obtain seed liquid;
the seed culture medium is as follows: 50g of glucose, 10g of peptone, 10g of yeast extract, 5g of sodium acetate, 0.2g of diammonium citrate, 0.2g of dipotassium hydrogen phosphate, 80mL of tween, 0.2g of magnesium sulfate, 0.02g of manganese sulfate and 0.01g of ferrous sulfate, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, and cooling to obtain the finished product;
(2) Lactic acid preparation: inoculating the seed solution into MRS culture medium according to volume of 2% of MRS culture medium, shake culturing at 37deg.C and 180r/min for 48 hr to obtain fermentation broth, namely lactic acid;
the MRS culture medium is as follows: 10g of peptone, 10g of beef extract, 5g of yeast extract, 2g of diammonium citrate, 5g of sodium acetate, 20g of glucose, 80mL of Tween, 0.5g of magnesium sulfate and 0.25g of manganese sulfate, adding distilled water to 1000mL, sterilizing at 121 ℃ for 25 minutes, and cooling to obtain the beef extract;
(3) And (3) measuring the content of lactic acid:
sampling the prepared fermentation liquor lactic acid at 4h, 8h, 12h, 16h, 20h and 24h, repeating each group of the fermentation liquor lactic acid at three times, centrifuging at the temperature of 4 ℃ and under the condition of 12000r/min for 8min, taking the supernatant to measure the content of lactic acid, oxidizing the lactic acid under the action of lactic acid dehydrogenase to generate pyruvic acid, reducing MTT to generate a purple substance, wherein the substance has a characteristic absorption peak at 570nm, calculating the content of lactic acid to be 2-11 g/L by utilizing the proportional relation between the lactic acid and the concentration of lactic acid, and determining the formula as follows:
Figure QLYQS_1
wherein: a represents absorbance of fermentation supernatant, A 0 The absorbance of the blank is represented by K, the slope of the standard curve, the intercept of the standard curve, and the conversion coefficient by 1176.67.
3. Use of lactococcus garvieae WBT0008 according to claim 1 for the preparation of a preparation for inhibiting harmful bacteria, characterized in that it comprises the steps of:
(1) Lactic acid bacteria preparation
The WBT0008 of the lactococcus garvieae is inoculated in an MRS liquid culture medium for shaking culture at 37 ℃ for 48 hours, and the concentration of the cultured thalli is 1 multiplied by 10 8 CFU/mL, centrifuging the bacterial liquid at 4 ℃ and 12000r/min for 20min to obtain a supernatant, thus obtaining a bacteriostatic agent for inhibiting harmful bacteria;
the harmful bacteria are staphylococcus aureus, salmonella or escherichia coli;
(2) Antibacterial Activity test
The antibacterial activity test adopts a filter paper sheet method, harmful bacteria are inoculated in LB liquid culture medium, shaking culture is carried out for 24 hours at 37 ℃, 200 mu L of bacteria liquid is absorbed and evenly coated on a nutrient agar plate, then a sterilized filter paper sheet with the diameter of 5mm is placed on the coated plate, 10 mu L of a centrifugal supernatant of a lactococcus garvieae agent is dripped on the filter paper sheet, and the culture is carried out for 24 hours at 37 ℃, and the diameter of an antibacterial ring is observed and measured.
4. The use of the lactococcus garvieae WBT0008 in preparing fresh steak preservative according to claim 1, wherein the lactococcus garvieae WBT0008 is inoculated in MRS liquid culture medium according to 2% of the volume of the MRS liquid culture medium, and cultured for 48 hours at 37 ℃ in a shaking table, and the concentration of cultured bacteria is 3 multiplied by 10 8 CFU/mL, then the bacterial liquid is centrifuged for 20min at the temperature of 4 ℃ and 12000r/min to obtain supernatant, the supernatant is uniformly sprayed on the surface of the fresh steak by a clean sterile watering can, and the fresh steak is completely covered by a sterile preservative film.
CN202111336937.2A 2021-11-12 2021-11-12 Lactic acid-producing lactococcus garvieae WBT0008 and application thereof Active CN113980853B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111336937.2A CN113980853B (en) 2021-11-12 2021-11-12 Lactic acid-producing lactococcus garvieae WBT0008 and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111336937.2A CN113980853B (en) 2021-11-12 2021-11-12 Lactic acid-producing lactococcus garvieae WBT0008 and application thereof

Publications (2)

Publication Number Publication Date
CN113980853A CN113980853A (en) 2022-01-28
CN113980853B true CN113980853B (en) 2023-05-26

Family

ID=79748127

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111336937.2A Active CN113980853B (en) 2021-11-12 2021-11-12 Lactic acid-producing lactococcus garvieae WBT0008 and application thereof

Country Status (1)

Country Link
CN (1) CN113980853B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114958667B (en) * 2022-05-27 2023-09-29 朱密 Lactococcus for high yield of L-lactic acid and application thereof
CN116083307B (en) * 2023-01-10 2024-05-07 四川轻化工大学 Lactococcus garvieae for producing esterase and ester compounds and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015071502A1 (en) * 2013-11-18 2015-05-21 Amadeite Extract of algae for use as an antibacterial agent
CN105385640A (en) * 2015-12-18 2016-03-09 广州市康优元生物科技有限公司 Lactococcus garviea and application thereof
CN105385729A (en) * 2015-12-18 2016-03-09 广州市康优元生物科技有限公司 Lactococcus garviea bacteriocin, preparing method thereof and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015071502A1 (en) * 2013-11-18 2015-05-21 Amadeite Extract of algae for use as an antibacterial agent
CN105385640A (en) * 2015-12-18 2016-03-09 广州市康优元生物科技有限公司 Lactococcus garviea and application thereof
CN105385729A (en) * 2015-12-18 2016-03-09 广州市康优元生物科技有限公司 Lactococcus garviea bacteriocin, preparing method thereof and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Garvieacin Q, a Novel Class II Bacteriocin fromLactococcus garvieae BCC 43578;Amonlaya Tosukhowong et al.;Applied and Environmental Microbiology;第78卷(第5期);第1619-1623页 *
乳酸菌在临床应用上的进展;刘锦秀 等;食品与发酵科技;52(第5期);第96-99、104页 *

Also Published As

Publication number Publication date
CN113980853A (en) 2022-01-28

Similar Documents

Publication Publication Date Title
CN113980853B (en) Lactic acid-producing lactococcus garvieae WBT0008 and application thereof
CN113980848B (en) Pediococcus pentosaceus SBC5 and application thereof
CN110791460B (en) Strain for inhibiting growth of aspergillus flavus and generation of toxin
CN103013861B (en) Preparation method of bacillus subtilis HJDA32 and bacteriocin generated by bacillus subtilis HJDA32
CN104087524A (en) Lactobacillus paracasei subsp. tolerans strain, screening method and use
CN113444664B (en) Lactobacillus brevis for producing gamma-aminobutyric acid and application thereof
CN114891700B (en) Bacillus coagulans C56, strain characteristics and application thereof
CN114908011B (en) Lactobacillus sausage and application thereof
CN106635916B (en) Acetobacter orientalis YZD-09 and application thereof
CN105176856A (en) Screening and culture method of lactobacillus sakei LZ217 and application thereof
CN111909878A (en) Lactobacillus casei with function of removing patulin
CN112251383A (en) Lactobacillus casei capable of producing phenyllactic acid and application thereof
CN110257302B (en) Screening method and application of lactobacillus strain with antioxidant capacity
CN109136129B (en) Lactobacillus acidophilus NCU426
CN112195118B (en) Lactobacillus plantarum PC28152 with broad-spectrum fungal inhibition activity and application thereof
CN107034161A (en) It is a kind of to produce Lactobacillus kefiranofaciens and its application in capsicum is fermented
CN1793325A (en) Aromatic type direct putting type ferment agent for sour milk
CN108865919B (en) Lactobacillus pentosus CICC6294 and application thereof in chili fermentation
CN113061550B (en) Lactobacillus new strain Z6 and application thereof in food
CN106591176B (en) Lactobacillus pentosus and application thereof
CN112458003B (en) Diacetyl-producing lactobacillus plantarum and application thereof in pickled vegetables
CN103865832A (en) Lactobacillus plantarum BS10 and application thereof in regulating pig blood fat
CN114058543B (en) Pediococcus acidilactici DY15, application thereof, feed and preparation method thereof
CN113355265B (en) Lactobacillus plantarum and application thereof
CN114836343B (en) Lactobacillus plantarum P10 capable of high-yielding gammA-Aminobutyric acid and antagonizing harmful bacteria and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant